Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vomiting × NDC80 protein, human × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Interventions

Dexamethasone 49 Aprepitant 38 Palonosetron 33 Ondansetron 29 Granisetron 22 Calcium Dobesilate 14 fosaprepitant 13 Olanzapine 13 dexamethasone acetate 7 Therapeutics 7 ramosetron 6 netupitant, palosentron drug combination 6 casopitant 6 Cyclophosphamide 6 dexamethasone 21-phosphate 5 Tropisetron 5 Radiotherapy 5 Metoclopramide 5 Doxorubicin 5 netupitant 4 dolasetron 4 Acupressure 4 Vincristine 3 Tablets 3 Prochlorperazine 3 Lorazepam 3 Electroacupuncture 3 Dronabinol 3 Diphenhydramine 3 Cisplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01366599 2017-05-24

CV Events in Emetogenic Chemotherapy

GlaxoSmithKline

12,058 enrolled

Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡